These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 15078924

  • 1. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.
    J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
    [Abstract] [Full Text] [Related]

  • 2. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW, Custer DM, Thompson E.
    Virology; 2003 Feb 01; 306(1):181-95. PubMed ID: 12620810
    [Abstract] [Full Text] [Related]

  • 3. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M, Pacchioni SM, Zanotto C, De Giuli Morghen C, Illiano E, Granucci F, Zanoni I, Broggi A, Radaelli A.
    Virus Res; 2013 Dec 26; 178(2):374-82. PubMed ID: 24050999
    [Abstract] [Full Text] [Related]

  • 4. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.
    J Virol; 2008 Apr 26; 82(7):3517-29. PubMed ID: 18199639
    [Abstract] [Full Text] [Related]

  • 5. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD.
    J Virol; 2005 Jun 26; 79(12):7845-51. PubMed ID: 15919938
    [Abstract] [Full Text] [Related]

  • 6. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW, Josleyn MD, Hooper JW.
    Vaccine; 2008 Jun 25; 26(27-28):3507-15. PubMed ID: 18485547
    [Abstract] [Full Text] [Related]

  • 7. Subunit recombinant vaccine protects against monkeypox.
    Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.
    J Immunol; 2006 Aug 15; 177(4):2552-64. PubMed ID: 16888017
    [Abstract] [Full Text] [Related]

  • 8. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
    Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, Ogata M, Fukushi S, Mizutani T, Sata T, Kurata T, Kurane I, Morikawa S.
    J Virol; 2006 Jun 15; 80(11):5179-88. PubMed ID: 16698998
    [Abstract] [Full Text] [Related]

  • 9. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J, King LR, Robert-Guroff M, Hryniewicz A, Venzon D, Meseda C, Weir J, Nalca A, Livingston V, Wells J, Lewis MG, Huggins J, Zwiers SH, Golding H, Franchini G.
    J Infect Dis; 2005 Feb 01; 191(3):372-81. PubMed ID: 15633096
    [Abstract] [Full Text] [Related]

  • 10. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.
    J Virol; 2008 Jul 01; 82(14):6829-37. PubMed ID: 18448519
    [Abstract] [Full Text] [Related]

  • 11. Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.
    Bissa M, Quaglino E, Zanotto C, Illiano E, Rolih V, Pacchioni S, Cavallo F, De Giuli Morghen C, Radaelli A.
    Antiviral Res; 2016 Oct 01; 134():182-191. PubMed ID: 27637905
    [Abstract] [Full Text] [Related]

  • 12. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
    Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL.
    Vaccine; 2011 Dec 06; 29(52):9684-90. PubMed ID: 22001879
    [Abstract] [Full Text] [Related]

  • 13. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT, Berhanu A, Bigger CB, Prigge J, Silvera PM, Grosenbach DW, Hruby D.
    Vaccine; 2020 Jan 16; 38(3):644-654. PubMed ID: 31677948
    [Abstract] [Full Text] [Related]

  • 14. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM, Golden JW, Hammerbeck CD, Kishimori JM, Royals M, Joselyn MD, Ballantyne J, Nalca A, Hooper JW.
    J Virol; 2022 Feb 09; 96(3):e0150421. PubMed ID: 34851148
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW, Golden JW, Ferro AM, King AD.
    Vaccine; 2007 Feb 26; 25(10):1814-23. PubMed ID: 17240007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
    Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.
    Vaccine; 2010 Sep 14; 28(40):6627-36. PubMed ID: 20659519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.